Bausch Health Companies (BHC) revenue and earnings history
Bausch Health Companies reported revenue of $10.3B for fiscal 2025 (year ended Dec 31, 2025), +6.7% on the year before, and net income of $157M.
Over 17 years, from fiscal 2008 to fiscal 2025, revenue grew at a compound rate of +16.6% a year.
Revenue and net income, 18 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $10.3B+6.7% | $1.81B | $157M | $1.4B | $397M | $1B | $216M | — | — | $1.31B | $20.8B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Bausch Health Companies (BHC) on OQRO.
Common questions
What was Bausch Health Companies's revenue in fiscal 2025?
$10.3B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 19, 2026. That is +6.7% on fiscal 2024 ($9.63B).
How fast has Bausch Health Companies's revenue grown?
From $757M in fiscal 2008 to $10.3B in fiscal 2025: a compound annual growth rate of +16.6% over 17 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Bausch Health Companies tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
